Inventor · disambiguated record
Thomas H. Aldrich
Also filed as: ALDRICH THOMAS · ALDRICH THOMAS H
18 granted patents·9 pending applications·630 citations·filing 1994–2019
96Inventor score
Top patents by PatentIndex Score
27 records- 0195US8597898B2Fusion polypeptides capable of activating receptorsREGENERON PHARMA·Filed 2012·Granted Dec 3, 2013·16 cites·22 claims
- 0295US7534604B2Fusion polypeptides capable of activating receptorsREGENERON PHARMA·Filed 2005·Granted May 19, 2009·41 cites·9 claims
- 0395US6166185AAntibodies to human TIE-2 ligandsREGENERON PHARMA·Filed 1998·Granted Dec 26, 2000·142 cites·2 claims
- 0494US8927233B2Fusion polypeptides capable of activating receptorsREGENERON PHARMA·Filed 2013·Granted Jan 6, 2015·16 cites·34 claims
- 0594US8865430B2Fusion polypeptides capable of activating receptorsREGENERON PHARMA·Filed 2013·Granted Oct 21, 2014·16 cites·15 claims
- 0693US5521073ATIE-2 ligand, and method of makingREGENERON PHARMA·Filed 1994·Granted May 28, 1996·116 cites·9 claims
- 0792US8470324B2Fusion polypeptides capable of activating receptorsREENERON PHARMACEUTICALS INC·Filed 2012·Granted Jun 25, 2013·18 cites·20 claims
- 0892US8298532B2Fusion polypeptides capable of activating receptorsFANDL JAMES P·Filed 2009·Granted Oct 30, 2012·19 cites·20 claims
- 0992US5879672ATie-2 ligand 1REGENERON PHARMA·Filed 1994·Granted Mar 9, 1999·97 cites·16 claims
- 1089US7063840B2TIE-2 ligands, methods of making and uses thereofREGENERON PHARMA·Filed 2002·Granted Jun 20, 2006·19 cites·11 claims
- 1189US5643755ANucleic acid encoding tie-2 ligandREGENERON PHARMA·Filed 1994·Granted Jul 1, 1997·72 cites·11 claims
- 1282US9758592B2Recombinant cell surface capture proteinsREGENERON PHARMA·Filed 2013·Granted Sep 12, 2017·3 cites·8 claims
- 1377US9840549B2Fusion polypeptides capable of activating receptorsREGENERON PHARMA·Filed 2014·Granted Dec 12, 2017·1 cites·30 claims
- 1474US6645484B1Method of blocking blood vessel growth using tie-2 ligand 2REGENERON PHARMA·Filed 2000·Granted Nov 11, 2003·5 cites·2 claims
- 1571US2019382465A1Fusion Polypeptides Capable Of Activating ReceptorsREGENERON PHARMA·Filed 2019·Application pending·0 cites
- 1669US10428135B2Fusion polypeptides capable of activating receptorsREGENERON PHARMA·Filed 2017·Granted Oct 1, 2019·0 cites·27 claims
- 1762US5747033AMethod of enhancing the biological activity of Eph family ligandsREGENERON PHARMA·Filed 1994·Granted May 5, 1998·24 cites·6 claims
- 1860US6433143B1Tie-2 ligandsREGENERON PHARMA·Filed 1995·Granted Aug 13, 2002·11 cites·3 claims
- 1960US2011165650A1Fusion Polypeptides Capable of Activating ReceptorsREGENERON PHARMA·Filed 2011·Application pending·0 cites
- 2058US5622862AAssay systems for trkB neurotrophin activityREGENERON PHARMA·Filed 1994·Granted Apr 22, 1997·14 cites·1 claims
- 2157US2018118852A1Recombinant Cell Surface Capture ProteinsREGENERON PHARMA·Filed 2017·Application pending·0 cites
- 2255US2003109677A1TIE-2 ligands, methods of making and uses thereofFiled 2002·Application pending·0 cites
- 2354US2002173627A1TIE-2 ligands, methods of making and uses thereofFiled 2002·Application pending·0 cites
- 2454US2003166858A1TIE-2 ligands, methods of making and uses thereofFiled 2002·Application pending·0 cites
- 2554US2014072979A1Isolating cells expressing secreted proteinsREGENERON PHARMA·Filed 2013·Application pending·0 cites
- 2650US2017241887A1Isolating Cells Expressing Secreted ProteinsREGENERON PHARMA·Filed 2017·Application pending·0 cites
- 2746US2014072980A1Isolating cells expressing secreted proteinsREGENERON PHARMA·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →